Program

PROGRAM

Program

Imprint

Privacy

Jörg Eickeler, Beratung · Organisation · Veranstaltung

Download the program as PDF:

Part I: Breast Cancer

09.30 am

Welcome and Introduction

J. Sehouli and J.-U. Blohmer

09.35 am

PRESIDENTIAL LECTURES

► Inherited Susceptibility to Breast Cancer · F. J. Couch

► Clinical Management of Hereditary Breast and Gynecologic

► Cancer · D. Speiser and U. Bick

10.15 am

STATE OF THE ART SESSION

Checkpoint Inhibitors and CDK4/6 Inhibitors in Breast Cancer

M. P. Goetz

10.35 am

SATELLITE SYMPOSIUM with kind support of Seagen

Oxford Debate: Therapy Options HER2-positive Metastatic Breast Cancer – Keep or Change the Mode of Action?

Chair: J.-U. Blohmer

► Welcome and Introduction to the Current AGO Therapy

► Recommendations for HER2-positive Metastatic Breast Cancer

► J.-U. Blohmer

► Keep the Mode of Action: W. Janni

► Change the Mode of Action: M. Schmidt

► Oxford Debate: Therapy Options HER2-positive Metastatic

► Breast Cancer – Keep or Change the Mode of Action?

► W. Janni and M. Schmidt

► Summary: J.-U. Blohmer

11.05 am

DEBATE

Value-Based Treatment Planning – Not Without Patient-Reported

Outcome (PRO)

► Charité Perspective: M. Karsten

► Mayo Perspective: K. Ruddy

11.35 am

SURGICAL GRAND ROUND

► Role of Axillary Dissection, Sentinel Node Biopsy and

► Radiotherapy of Axillary Lymph Nodes · J. Boughey

► BI-ALCL · J. Kricheldorff

11.55 am

SATELLITE SYMPOSIUM with kind support of AstraZeneca

Precision Medicine in Breast Cancer

Chair: J.-U. Blohmer

► Early Breast Cancer, BRCA-mutated: D. Speiser

► Metastatic Breast Cancer, HER2-positive: S. Kümmel

12.55 am

Break

Part II: Ovarian Cancer

PRESIDENTIAL LECTURES

Ovarian Cancer Management: Yesterday, Today, Tomorrow

► Surgery: A. du Bois

► Medical Therapy: J. A. Ledermann

STATE OF THE ART SESSION

Maintenance Therapy

► First-Line Therapy: E. I. Braicu

► Second-Line Therapy: J. Sehouli

► Discussion: all speakers plus I. Ray-Coquard, A. Gonzalez

SATELLITE SYMPOSIUM with kind support of GlaxoSmithKline

The Patient at the Center of the Therapy Algorithm in Ovarian

Cancer – Challenges Today and Tomorrow

► Potential De-Escalation of Chemotherapy After Successful

► Surgery (R0)? – Connection with Biomarker Status and Effective

► Maintenance Therapy · J. Sehouli

► The Benefit of Combination Therapy – Is the PARPi the Driver of

► Efficacy? · P. Harter

PRO/CON DEBATE

Neoadjuvant vs. Adjuvant Therapy

► Charité Perspective: R. Chekerov, E. I. Braicu, J. Sehouli

► Mayo Perspective: A. E. Wahner-Hendrickson, J. Weroha,

► J. Bakkum-Gamez

► Discussion: all speakers plus R. Coleman, C. Marth

Break

01.15 pm

01.55 pm

02.25 pm

02.55 pm

03.20 pm

03.50 pm

EDUCATIONAL SESSION

Enhanced Recovery after Surgery (ERAS)

► Charité Perspective: M. G. Inci, M. Lee, J. Sehouli

► Mayo Perspective: S. Dowdy, J. Bakkum-Gamez, G. Glaser

► Discussion: all speakers plus C. Fotopoulou, G. Nelson

Part III: Endometrial Cancer

PRESIDENTIAL LECTURES

Endometrial Cancer Management: Yesterday, Today, Tomorrow

► Surgery: D. Cibula

► Medical Therapy: N. Colombo

04.05 pm

STATE OF THE ART SESSION

► Molecular Diagnostics: M. Hummel

► Relapsed Endometrial Cancer: Surgery vs. No Surgery

► A. E. Wahner-Hendrickson and J. Bakkum-Gamez

► Discussion: all speakers plus N. Concin and B. Monk

04.45 pm

SATELLITE SYMPOSIUM with kind support of Incyte

Beyond Chemotherapy in Advanced Endometrial Cancer:

A Possible Change of Paradigm

Where have We Been? Where are We? What are the Next

Milestones?

J. Sehouli

05.15 pm

PRO/CON DEBATE

Relapsed Endometrial Cancer: Non-Chemotherapy Options

► GARNET / Monotherapy: K. Pietzner

► KEYNOTE-158 / Combination Therapy: V. Makker

► Charité Perspective: I. Braicu, K. Pietzner, J. Sehouli

► Mayo Perspective: J. Bakkum-Gamez

► Discussion: all speakers

05.45 pm

EDUCATIONAL SESSION

► Sentinel Node Technique: N. Abu-Rustum

► Charité Perspective: M. Z. Muallem, R. Armbrust, J. Sehouli

► Mayo Perspective: A. Mariani, G. Glaser, M. Shahi

► Discussion: all speakers plus A. Karam and A. Fagotti

06.15 pm

SATELLITE SYMPOSIUM with kind support of Novocure

Treatments in Platinum-Resistant Ovarian Cancer (PROC) –

Past, Present and Future Perspectives

► What are the Keys to Successful Clinical Trials in PROC?

► Looking at Treatment Concepts in PROC: What is Novel, what

► is Exciting?

► What will PROC Treatment Look Like in the Future?

► What does the Future of Biomarkers Look Like?

► Role of Maintenance Therapy in PROC?

B. Monk, I. Ray-Coquard, R. Coleman, J. Sehouli

06.45 pm

LEARNING FROM THE MOST COMPLEX CASE OF THE YEAR

► Charité Perspective: C. L. Krause

► Mayo Perspective: A. Kumar

07.15 pm

CLOSING SESSION

WITH AWARDING OF THE THREE BEST POSTERS

J. Sehouli and J.-U. Blohmer

07.30 pm

Berlin Cultural Highlight of the Day

07.45 pm

SPEAKERS, DISCUSSANTS, CHAIRS

Prof. Dr. Nadeem R. Abu-Rustum, New York, NY (USA)

Dr. med. Robert Armbrust, Berlin (D)

Prof. Dr. Jamie N. Bakkum-Gamez, Rochester, MN (USA)

Prof. Dr. med. Ulrich Bick, Berlin (D)

Prof. Dr. med. Jens-Uwe Blohmer, Berlin (D)

Prof. Dr. med. Dr. h.c. Andreas du Bois, Essen (D)

Prof. Dr. Judy C. Boughey, Rochester, MN (USA)

Prof. Dr. med. Elena Ioana Braicu, Berlin (D)

Dr. med. Radoslav Chekerov, Berlin (D)

Prof. Dr. David Cibula, Prague (CZ)

Prof. Dr. William A. Cliby, Rochester, MN (USA)

Prof. Dr. Robert L. Coleman, The Woodlands, TX (USA)

Prof. Dr. Nicoletta Colombo, Milan (I)

Prof. Dr. med. Nicole Concin, Innsbruck (A) + Essen (D)

Prof. Dr. Fergus J. Couch, Rochester, MN (USA)

Prof. Dr. Sean C. Dowdy, Rochester, MN (USA)

Prof. Dr. Anna Fagotti, Rome (I)

Prof. Dr. Christina Fotopoulou, Berlin (D) + London (UK)

Dr. Gretchen E. Glaser, Rochester, MN (USA)

Prof. Dr. Matthew P. Goetz, Rochester, MN (USA)

Dr. Antonio González Martín, Madrid (E)

Prof. Dr. med. Philipp Harter, Essen (D)

Prof. Dr. rer. nat. Michael Hummel, Berlin (D)

Dr. med. Melisa Gülhan Inci, Berlin (D)

Prof. Dr. med. Wolfgang Janni, Ulm (D)

Dr. Amer Karam, Stanford, CA (USA)

Dr. med. Maria Karsten, Berlin (D)

Dr. med. Catherine L. Krause, Berlin (D)

Dr. med. Julian Kricheldorff, Berlin (D)

Dr. Amanika Kumar, Rochester, MN (USA)

Prof. Dr. med. Sherko Kümmel, Essen (D)

Prof. Dr. Jonathan A. Ledermann, London (UK)

Marlene Lee, Berlin (D)

Dr. Vicky Makker, New York, NY (USA)

Prof. Dr. Andrea Mariani Rochester, MN (USA)

Prof. Dr. med. Christian Marth, Innsbruck (A)

Prof. Dr. Bradley Monk, Phoenix, AZ (USA)

PD Dr. med. Dr. (syr) Mustafa Zelal Muallem, Berlin (D)

Prof. Dr. Gregg Nelson, Calgary (CND)

PD Dr. med. Klaus Pietzner, Berlin (D)

Prof. Dr. Isabelle Ray-Coquard, Lyon (F)

Dr. Kathryn J. Ruddy, Rochester, MN (USA)

Prof. Dr. med. Marcus Schmidt, Mainz (D)

Prof. Dr. med. Dr. h.c. Jalid Sehouli, Berlin (D)

Prof. Dr. Maryam Shahi, Rochester, MN (USA)

Prof. Dr. med. Dorothee Speiser, Berlin (D)

Dr. Andrea E. Wahner Hendrickson, Rochester, MN (USA)

Dr. Saravut J. Weroha, Rochester, MN (USA)

Streamed at the conference platform after the sientific program

ROBIN GOOCH

AMERICAN OPERA AND GOSPEL SINGER

with a

MUSICAL PERFORMANCE

especially for the CMC 2022